Working… Menu
Trial record 10 of 19 for:    Venetoclax AND Bendamustine

A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01671904
Recruitment Status : Active, not recruiting
First Posted : August 24, 2012
Last Update Posted : December 4, 2019
AbbVie (prior sponsor, Abbott)
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : August 17, 2018
Estimated Study Completion Date : December 31, 2019